Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 01, 2026
Evonik will invest more than 150 million Canadian dollars, or about $109 million, to build a new good manufacturing practice drug-product facility in Vancouver, Canada, expanding its capacity for lipid-based drug delivery products including vaccines,...
read more
Tuesday, September 01, 2026
Andelyn Biosciences has been selected by Genprex Inc. to support manufacturing scale-up for an adeno-associated virus-based gene therapy program being developed for Type 1 and Type 2 diabetes.
read more
Tuesday, September 01, 2026
Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare.
read more
Tuesday, September 01, 2026
Samsung Biologics has published the formal prospectus for its planned acquisition of PolyPeptide Group AG, offering about $55.70 in cash per share in a transaction that values the Swiss peptide manufacturer’s equity at approximately $1.83 billion.
read more
Thursday, August 27, 2026
4basebio and Genezen have expanded a non-exclusive collaboration intended to give cell and gene therapy developers access to synthetic, cell-free DNA for viral vector development and clinical programs.
read more
Thursday, August 27, 2026
Artis BioSolutions has launched a Genetic Medicines Center of Excellence in Bilbao, Spain, adding mRNA and lipid nanoparticle development and manufacturing capabilities to its platform for genetic medicines.
read more
Wednesday, August 26, 2026
Lonza has appointed Samanta Cimitan as chief commercial officer, senior vice president and a member of its Extended Executive Committee, creating a role intended to strengthen customer engagement and establish a unified commercial approach across the...
read more
Wednesday, August 26, 2026
Centrix Pharma Solutions has partnered with the University of Sussex on a £375,000 Knowledge Transfer Partnership aimed at using data analytics and predictive modeling to improve pharmaceutical product development.
read more
Wednesday, August 26, 2026
Symbiosis Pharmaceutical Services has appointed Jay Chima as vice president of business development as the aseptic fill-finish contract development and manufacturing organization expands its commercial team amid growing demand for biologics, advanced...
read more
Halo Pharma is in the final operational stages of activating a new sterile injectable manufacturing line at its Whippany, New Jersey, facility, following a $45 million investment intended to add domestic capacity for pharmaceutical companies.
read more
Hovione has completed a more than €40 million expansion of its tablet development and manufacturing center in Loures, Portugal, adding commercial-scale batch tableting capacity for oral solid dosage products.
read more
Cambrex has completed pre-approval inspections by the U.S. FDA, Japan’s Pharmaceuticals and Medical Devices Agency and Australia’s Therapeutic Goods Administration at its High Point, North Carolina facility, enabling the site to manufacture approved ...
read more
Chai Discovery has entered a collaboration with Bristol Myers Squibb to support the discovery of therapeutic antibody candidates using artificial intelligence.
read more
Thursday, August 20, 2026
VectorBuilder and Lir Therapeutics have formed a strategic collaboration to develop adeno-associated virus capsids designed to combine biological performance with the manufacturability and scalability needed for clinical gene-therapy programs.
read more
Thursday, August 20, 2026
Charles River Laboratories International and Medigen Vaccine Biologics Corp. have formed a collaboration to support development of Medigen’s next-generation multivalent enterovirus vaccine through next-generation sequencing and other analytical and ...
read more